Biolegend, 640943, Alexa Fluor® 647 Annexin V, 300tests

Annexin V (or Annexin A5) is a member of the annexin family of intracellular proteins that binds to phosphatidylserine (PS) in a calcium-dependent manner. PS is normally only found on the intracellular leaflet of the plasma membrane in healthy cells, but during early apoptosis, membrane asymmetry is lost and PS translocates to the external leaflet. Fluorochrome-labeled Annexin V can then be used to specifically target and identify apoptotic cells.Annexin V Binding Buffer (cat. no. 422201) is recommended for use with Annexin V staining.Annexin V binding alone cannot differentiate between apoptotic cells and necrotic. Therefore, we recommend using our Helix NP™ Blue (Cat. No. 425305), Helix NP™ Green (Cat. No. 425303) or Helix NP™ NIR (Cat. No. 425301). Early apoptotic cells will exclude 7-AAD and PI, while late stage apoptotic cells and necrotic cells will stain positively, due to the passage of these dyes into the nucleus where they bind to DNA.
300tests
Verified Reactivity: Human, Mouse, Rat
Reported Reactivity: Other Species
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation: The purified protein was conjugated with Alexa Fluor® 647 under optimal conditions.
Concentration: Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling: The Annexin V solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this product is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µL per 100,000 - million cells in a 100 µL volume of Annexin V Binding Buffer (Cat No. 422201). It is recommended that the reagent be titrated for optimal performance for each application. * Alexa Fluor® 647 has a maximum emission of 668 nm when it is excited at 633nm / 635nm. Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.View full statement regarding label licenses
Excitation Laser: Red Laser (633 nm)
Application Notes: Annexin V Staining Wash cells twice with cold BioLegend Cell Staining Buffer (Cat. No. 420201) and then resuspend cells in Annexin V Binding Buffer (Cat. No. 422201) at a concentration of 1x106 cells/mL. Transfer 100 µL of cell suspension in 5 mL test tube. Add 5 µL of fluorochrome conjugated Annexin V. Stain with a viability dye, such as PI (Cat. No. 421301), 7-AAD (Cat. Nos. 420403 & 420404), or Helix NP dyes (Cat. Nos. 425301, 425303, & 425305), if desired. Gently vortex the cells and incubate for 15 min at RT (25°C) in the dark. Add 400* µL of Annexin V Binding Buffer (Cat. No. 422201) to each tube. *For more concentrated samples, add a minimum of 200 µl of Annexin V Binding Buffer in this step. Analyze by flow cytometry. For a better experience detecting apoptosis, we now recommend Apotracker™. Cell staining with Apotracker™ is Calcium independent. Thus, no special buffers are required, and the protocol can be shortened for single-step co-staining with other reagents.
Application References(PubMed link indicates BioLegend citation): Koopman G, et al. 1994. Blood 84:1415. Vermes I, et al. 1995. J. Immunol. Methods 184:39. Dachary-Prigent J et al. 1993. Blood 81:2554. Lev S, et al. 2010. J. Biol Chem. 287:2771. PubMed Jin D, et al. 2010. Cancer Res. 70:2245. PubMed Santidrian AF, et al. 2010. Blood 116:3023. PubMed Zammarchi, F., et al. 2011. PNAS. 108:17779. PubMed Liu F, et al. 2011. Cancer Res. 71:6807. PubMed Wortmann A, et al. 2011. J Biol Chem. 286:42303. PubMed Yang D, et al. 2012. J Immunol. 188:4441. PubMed Notake T, et al. 2012. J Immunol. 188:4838. PubMed Liu F, et al. 2012. J. Biol Chem. 287:25530. PubMed Schmid M, et al. 2012. Immunobiology. 217:610. PubMed Topalov NN, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2475. PubMed Xu LS, et al. 2012. J. Immunol. 189:3347. PubMed Gobeil PA, et al. 2012. MBio. 16:267. PubMed Abaeva AA, et al. 2013. J Biol Chem. 288:29621. PubMed Ponzetta A, et al. 2013. J. Immunol. 191:5684. PubMed Beggs KM, et al. 2014. Toxicol Sci. 137:91. PubMed Yue D, et al. 2014. Exp Cell Res. 322:149. PubMed Schott J, et al. 2014. PLoS Genet. 10:1004368. PubMed Yasunaga M, et al. 2014. Sci Rep. 4:4852. PubMed Schogler A, et al. 2015. Eur Respir J. 45:428. PubMed Zakharova NV, et al. 2015. PLoS One. 10:116665. PubMed Ghalei H, et al. 2015. J Cell Biol. 208:745. PubMed
Product Citations: Kitazawa M, et al. 2017. PLoS One. 10.1371/journal.pone.0169340. PubMed Berthenet K, et al. 2020. Cell Rep. 31:107731. PubMed Li W, et al. 2019. Aging (Albany NY). 0.99375. PubMed Rashid R, et al. 2019. Sci Data. 0.474305556. PubMed Wang YH, et al. 2022. Sci Adv. 8:eabn6552. PubMed Wagner AR, et al. 2022. Elife. 11:. PubMed Reynolds MB, et al. 2023. Sci Adv. 9:eade8701. PubMed Dufour S, et al. 2023. Commun Biol. 6:207. PubMed Cannavicci A, et al. 2023. Int J Mol Sci. 24:. PubMed Harpur CM, et al. 2023. Clin Transl Immunology. 12:e1443. PubMed Whyte D, et al. 2023. Mol Oncol. . PubMed Capellmann S, et al. 2023. Front Immunol. 14:1154416. PubMed Liu JC, et al. 2023. Int J Mol Sci. 24:. PubMed Sarno J, et al. 2023. Nat Commun. 14:2935. PubMed Ma X, et al. 2023. Research (Wash D C). 6:0124. PubMed Forika G, et al. 2021. Pathol Oncol Res. 27:1610048. PubMed Manzano-Muñoz A, et al. 2022. NPJ Precis Oncol. 6:90. PubMed Berastegui N, et al. 2022. Nat Commun. 13:7619. PubMed Pinci F, et al. 2022. Front Immunol. 13:1074440. PubMed Herz J, et al. 2015. J Exp Med. 212: 1153 - 1169. PubMed Liu X, et al. 2018. Bioorg Med Chem. 26:3925. PubMed Kanagalingam T, et al. 2019. Immun Inflamm Dis. 0.369444444. PubMed Leib P 2012. MBio. 16:267. PubMed Abaeva A, et al. 2013. J Biol Chem. 288:29621. PubMed Alcon C, et al. 2020. Cell Death Dis. 0.898611111. PubMed Csomós I, et al. 2021. Int J Mol Sci. 22:. PubMed Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed Schlicher L, et al. 2016. EMBO Rep. 17: 1485 - 1497. PubMed Xu L, et al. 2012. J Immunol. 189:3347. PubMed Hug N, et al. 2022. RNA. 28:1224. PubMed Hinterbrandner M, et al. 2021. JCI Insight. 6:e151797. PubMed Ohtsuka S, et al. 2016. Int Immunol. 28: 547 - 557. PubMed He Y, et al. 2020. Nat Commun. 11:1996. PubMed Wurzer H, et al. 2021. Front Immunol. 12:619069. PubMed Rashad S, et al. 2021. J Cell Physiol. 236:3710. PubMed Lopez J, et al. 2016. Nat Commun. 7:10538. PubMed Zakharova N, et al. 2015. PLoS One. 10:116665. PubMed Wortmann A, et al. 2011. J Biol Chem. 286:42303. PubMed Tian AL, et al. 2021. Cell Death Dis. 12:6. PubMed Schögler A, et al. 2015. Eur Respir J. 45:428. PubMed Artemenko E, et al. 2016. Biochem J. 473: 435 - 448. PubMed Lin JR et al. 2018. eLife. 7 pii: e31657. PubMed Wu X, et al. 2020. Front Biosci (Landmark Ed). 25:513. PubMed Yue D, et al. 2014. Exp Cell Res. 322:149. PubMed Park A, et al. 2016. PLoS One. 11: 0148998. PubMed Coe G, et al. 2016. Sci Rep. 6:30816. PubMed Wiedemann GM, et al. 2020. Cell Rep. 33:108498. PubMed Lev S, et al. 2010. J Biol Chem. 285:2771. PubMed Notake T, et al. 2012. J Immunol. 188:4838. PubMed Zhang X, et al. 2020. Eur J Med Chem. 112186:192. PubMed Yue D, et al. 2015. Exp Cell Res. 336: 141-149. PubMed Fan Z, et al. 2019. Aging (Albany NY). 0.85625. PubMed Carosi JM, et al. 2021. Autophagy. 17:2217. PubMed Smith CM, et al. 2021. Biochem J. 478:3331. PubMed Schott J, et al. 2014. PLoS Genet. 10:1004368. PubMed Matsumura M 2014. Sci Rep. 4:4852. PubMed Ghalei H, et al. 2015. J Cell Biol. 208:745. PubMed Mair B, et al. 2016. PLoS Genet. 12: 1006279. PubMed Zhang Y, et al. 2020. Aging (Albany NY). 12:8067. PubMed Liu F, et al. 2011. Cancer Res. 71:6807. PubMed Jin D, et al. 2010. Cancer Res. 70:2245. PubMed Bersini S, et al. 2020. Life Sci Alliance. 3:e201900623. PubMed Hosokawa T, et al. 2017. J Immunol. 10.4049/jimmunol.1700157. PubMed Ma W, et al. 2017. Cell Death & Disease. 10.1038/cddis.2017.47. PubMed Rashad S, et al. 2020. RNA Biol. 1092:17. PubMed Adams O, et al. 2018. PLoS One. 13:e0197610. PubMed Pal P, et al. 2021. J Med Chem. 64:14230. PubMed Kinoshita M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed Canedo EC, et al. 2021. JCI Insight. 6:. PubMed Basu T, et al. 2021. Hemasphere. 5:e565. PubMed Bobylev I, et al. 2017. Neurotox Res.. 10.1007/s12640-017-9760-7. PubMed Mendelson A, et al. 2019. JCI Insight. 4:e126982. PubMed Zimmerman M, et al. 2010. PLoS One. 5:e14076. PubMed Manzano-Muñoz A, et al. 2021. Front Cell Dev Biol. 9:695225. PubMed Podoplelova N, et al. 2016. Blood. 128: 1745 - 1755. PubMed Bao W, et al. 2016. Sci Rep. 6:22579. PubMed Alcon C, et al. 2021. Cells. 10:. PubMed Liu F, et al. 2012. J Biol Chem. 287:25530. PubMed Beggs K, et al. 2014. Toxicol Sci. 137:91. PubMed Akhtar N, et al. 2016. Dev Cell. 38: 522-535. PubMed Yang D, et al. 2012. J Immunol. 188:4441. PubMed Ghura H, et al. 2021. Neoplasia. 23:837. PubMed Gomez J, et al. 2016. J Immunol. 197: 2864 - 2879. PubMed Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed Camacho K, et al. 2015. J Control Release. 210: 198-207. PubMed He Y, et al. 2020. J Hematol Oncol. 0.607638889. PubMed Geary CD et al. 2018. Cell reports. 24(8):1949-1957 . PubMed Qiao Y,et al. 2017. Oncogene. . 10.1038/onc.2017.387. PubMed Topalov N, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2475. PubMed Ponzetta A, et al. 2013. J Immunol. 191:5684. PubMed K?fer R, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.05.003. PubMed Lima PDA, et al. 2018. Biol Reprod. 99:838. PubMed Ho J, et al. 2011. PLoS One. 6:e16815. PubMed Jatho A, et al. 2022. Cells. 11:. PubMed Mauro AN, et al. 2022. Sci Rep. 12:14537. PubMed Duell J, et al. 2017. Leukemia. 10.1038/leu.2017.41. PubMed Schmid M, et al. 2012. Immunobiology. 217:610. PubMed Zammarchi F, et al. 2011. Proc Natl Acad Sci U S A. 108:17779. PubMed Zeevi D, et al. 2010. J Cell Sci. 123:3112. PubMed Santidrián A, et al. 2010. Blood. 116:3023. PubMed Lin PB, et al. 2019. Oncol Rep. 41:3377. PubMed Vulin M, et al. 2022. Oncogene. :. PubMed
RRID: AB_2561293 (BioLegend Cat. No. 640911) not an antibody (BioLegend Cat. No. 640912) AB_2616658 (BioLegend Cat. No. 640943)
Biology Area: Apoptosis/Tumor Suppressors/Cell Death, Cell Biology, Neuroscience
Gene ID: 308
UniProt: View information about Annexin V on UniProt.org
Regulatory Status: RUO
Other Names: Annexin A5, Dead, Apoptosis
Q: How is your Annexin made and what sequence does it cover?
A: It is made in E. coli, covering human aa Met1-Asp320.
Q: How does pH and staining temperature affect Annexin V-Phosphatidylserine binding?
A: Annexin-Phosphatidylserine binding is lost below pH 5.2 and with prolonged incubation over a temperature of 42°C.
Q: Why do I need to use Annexin V Binding Buffer?
A: Annexin V binding requires the presence of calcium in the solution.  So, we provide Annexin V Binding Buffer (cat # 422201), which is optimized for the best performance of Annexin V staining.
Q: Can I use RPMI during Annexin V staining?
A: It is best to follow protocol as described on the product data sheet. Moreover, RPMI 1640 has a relatively high concentration of phosphate and low calcium ion concentration, which negatively impacts Annexin binding to its target phosphatidylserine (PS). Measurement of cell death by using Annexin V may also be significantly affected by time of incubation on ice, calcium concentration, and type of medium.
Q: Can I freeze Annexin V conjugates?
A: It should not be frozen as it will lead to loss of biological activity due to dimerization.
Q: Is Annexin V suitable for conjugation with the Maxpar® kit for CyTOF®?
A: Maxpar® Labeling kits require the protein to be partially reduced, so the metal chelate can be introduced through an SH group in the hinge region of the reduced antibody. Human Annexin V contains only one Cysteine which was reported to be chemically inactive. Thus, the Maxpar® labeling protocol would not work with Annexin V, unless a free –SH group can be introduced to Annexin V.  For more information regarding SH-mediated conjugation of Annexin V please consult published papers such as this one.